Literature DB >> 19641001

Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses.

Jun Yin1, Christina L Gardner, Crystal W Burke, Kate D Ryman, William B Klimstra.   

Abstract

Venezuelan equine encephalitis virus (VEEV) is highly virulent in adult laboratory mice, while Sindbis virus (SINV) is avirulent regardless of dose or inoculation route, dependent upon functioning alpha/beta interferon (IFN-alpha/beta) responses. We have examined each virus' resistance to and/or antagonism of IFN-alpha/beta responses in neurons, a cell type targeted by both viruses in mice, by infecting IFN-alpha/beta-treated or untreated primary cultures with viruses or virus-derived replicons that lacked the structural proteins. Priming with IFN-alpha/beta prior to infection revealed that VEEV replication and progeny virion production were resistant to an established antiviral state while those of SINV were more sensitive. Postinfection IFN-alpha/beta treatment revealed that phosphorylation of STAT1 and STAT2 was partially blocked by infection with either virus, dependent upon expression of nonstructural proteins (nsP), but not structural proteins (sP). However, inhibition of STAT phosphorylation by VEEV replicons was not correlated with inhibition of IFN-stimulated gene (ISG) mRNA induction, yet ISG induction was inhibited when sP were present. Host translation was inhibited by VEEV nsP even when cells were pretreated with IFN-alpha/beta. SINV blocked ISG induction and translation, associated with nsP-mediated shutoff of macromolecular synthesis, but both activities were sensitive to IFN-alpha/beta pretreatment. We conclude that both VEEV and SINV limit ISG induction in infected neurons through shutoff of host transcription and translation but that inhibition by VEEV is more resistant to IFN-alpha/beta priming. Likewise, both viruses inhibit IFN receptor-initiated signaling, although the effect upon host responses is not clear. Finally, VEEV appears to be more resistant to effectors of the preestablished antiviral state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641001      PMCID: PMC2748036          DOI: 10.1128/JVI.01209-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

2.  Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006.

Authors:  Jérôme Lemant; Véronique Boisson; Arnaud Winer; Laure Thibault; Hélène André; François Tixier; Marie Lemercier; Emmanuel Antok; Marie Pierre Cresta; Philippe Grivard; Mathieu Besnard; Olivier Rollot; François Favier; Michel Huerre; José L Campinos; Alain Michault
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

3.  Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanism.

Authors:  Mulu Z Tesfay; Jun Yin; Christina L Gardner; Mikhail V Khoretonenko; Nadejda L Korneeva; Robert E Rhoads; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

4.  The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.

Authors:  Rennos Fragkoudis; Lucy Breakwell; Clive McKimmie; Amanda Boyd; Gerald Barry; Alain Kohl; Andres Merits; John K Fazakerley
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

5.  Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.

Authors:  Natalia Garmashova; Svetlana Atasheva; Wenli Kang; Scott C Weaver; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  Upregulation of a small subset of genes drives type I interferon-induced antiviral memory.

Authors:  Diego A Jaitin; Gideon Schreiber
Journal:  J Interferon Cytokine Res       Date:  2007-08       Impact factor: 2.607

7.  Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons.

Authors:  Kate D Ryman; Kathryn C Meier; Christina L Gardner; Patrick A Adegboyega; William B Klimstra
Journal:  Virology       Date:  2007-08-02       Impact factor: 3.616

8.  Identification and characterization of interferon-induced proteins that inhibit alphavirus replication.

Authors:  Yugen Zhang; Crystal W Burke; Kate D Ryman; William B Klimstra
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo.

Authors:  Jennifer L Konopka; Luiz O Penalva; Joseph M Thompson; Laura J White; Clayton W Beard; Jack D Keene; Robert E Johnston
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

10.  A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Authors:  Thérèse Couderc; Fabrice Chrétien; Clémentine Schilte; Olivier Disson; Madly Brigitte; Florence Guivel-Benhassine; Yasmina Touret; Georges Barau; Nadège Cayet; Isabelle Schuffenecker; Philippe Desprès; Fernando Arenzana-Seisdedos; Alain Michault; Matthew L Albert; Marc Lecuit
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  37 in total

1.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

2.  Viral infection leading to brain dysfunction: more prevalent than appreciated?

Authors:  Anthony N van den Pol
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

3.  Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.

Authors:  Dal Young Kim; Svetlana Atasheva; Niall J Foy; Eryu Wang; Elena I Frolova; Scott Weaver; Ilya Frolov
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.

Authors:  Jelke J Fros; Wen Jun Liu; Natalie A Prow; Corinne Geertsema; Maarten Ligtenberg; Dana L Vanlandingham; Esther Schnettler; Just M Vlak; Andreas Suhrbier; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Øyvind Haugland; Inderjit S Marjara; Øystein Evensen
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

6.  Macromolecular Synthesis Shutoff Resistance by Myeloid Cells Is Critical to IRF7-Dependent Systemic Interferon Alpha/Beta Induction after Alphavirus Infection.

Authors:  Nishank Bhalla; Christina L Gardner; Sierra N Downs; Matthew Dunn; Chengqun Sun; William B Klimstra
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 7.  Alphaviruses suppress host immunity by preventing myeloid cell replication and antagonizing innate immune responses.

Authors:  Derek W Trobaugh; William B Klimstra
Journal:  Curr Opin Virol       Date:  2017-03-10       Impact factor: 7.090

8.  Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.

Authors:  Sharmila Nair; Subhajit Poddar; Raeann M Shimak; Michael S Diamond
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

9.  A determinant of Sindbis virus neurovirulence enables efficient disruption of Jak/STAT signaling.

Authors:  Jason D Simmons; Amy C Wollish; Mark T Heise
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

10.  Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein.

Authors:  Catherine C Cruz; Mehul S Suthar; Stephanie A Montgomery; Reed Shabman; Jason Simmons; Robert E Johnston; Thomas E Morrison; Mark T Heise
Journal:  Virology       Date:  2010-01-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.